← Leaderboards
Daria Ilatovskaya
Medical College Of Wisconsin
$4,969,800
Attributed
$4,969,800
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $976.5K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,969,800 · 4
By mechanism
R01$2,760,089 · 1
U54$1,283,153 · 1
R00$747,000 · 1
K99$179,558 · 1
Top collaborators
No co-investigators on record.
Most similar at Medical College Of Wisconsin
Same institution · by research overlap
- Balaraman Kalyanaraman$20,398,607
- James S Hyde$25,933,368
- Tengis S Pavlov$2,477,539
- Earnestine Willis$4,929,457
- William J O'Brien$3,695,510
Others in their field
Top investigators on “Sodium”
- Pedro A. Jose · George Washington University$30,782,822
- Susan M Catalano · Cognition Therapeutics, Inc.$26,057,912
- Reshan Fernando · Research Triangle Institute$23,638,227
- Clifford J Woolf · Boston Children'S Hospital$22,198,198
- Christopher H Van Dyck · Cognition Therapeutics, Inc.$21,412,038
- Paul S. Aisen · Cognition Therapeutics, Inc.$21,412,038
Research focus
SodiumProductionAffectMolecularRattusKidneyMediatingAnimalsChronicElectrophysiology (Science)MeasurementIn VivoCellsRegulationAttenuatedDuct (Organ) StructureNephronsEventEpithelial Na+ ChannelPathologicBlood PressurePharmaceutical PreparationsDesignBlood Pressure Monitors
Grant awards (16)
Improving awareness of women with hypertension: ROAR (Rural, Obese, At Risk) Career Enhancement Core$419,641
U54 · FY2025 · HL · contact PI
Mitochondria-mediated effects and therapeutic potential of Atrial Natriuretic Peptide in salt-sensitive hypertension$514,879
R01 · FY2024 · HL · contact PI
Improving awareness of women with hypertension: ROAR (Rural, Obese, At Risk) Career Enhancement Core$412,417
U54 · FY2024 · HL · contact PI
Mitochondria-mediated effects and therapeutic potential of Atrial Natriuretic Peptide in salt-sensitive hypertension$525,386
R01 · FY2023 · HL · contact PI
Improving awareness of women with hypertension: ROAR (Rural, Obese, At Risk) Career Enhancement Core$451,095
U54 · FY2023 · HL · contact PI
Mitochondria-mediated effects and therapeutic potential of Atrial Natriuretic Peptide in salt-sensitive hypertension$525,386
R01 · FY2022 · HL · contact PI
Mitochondria-mediated effects and therapeutic potential of Atrial Natriuretic Peptide in salt-sensitive hypertension$569,432
R01 · FY2021 · HL · contact PI
Mitochondria-mediated effects and therapeutic potential of Atrial Natriuretic Peptide in salt-sensitive hypertension$44,564
R01 · FY2021 · HL · contact PI
Mitochondria-Mediated Effects and Therapeutic Potential of Atrial Natriuretic Peptide in Salt-Sensitive Hypertension Diversity Supplement$26,968
R01 · FY2021 · HL · contact PI
Mitochondria-mediated effects and therapeutic potential of Atrial Natriuretic Peptide in salt-sensitive hypertension$553,474
R01 · FY2020 · HL · contact PI
The involvement of ATP-dependent inhibition of ENaC in ARPKD cystogenesis$227,913
R00 · FY2020 · DK · contact PI
The involvement of ATP-dependent inhibition of ENaC in ARPKD cystogenesis$21,087
R00 · FY2020 · DK · contact PI
The involvement of ATP-dependent inhibition of ENaC in ARPKD cystogenesis$249,000
R00 · FY2019 · DK · contact PI
The involvement of ATP-dependent inhibition of ENaC in ARPKD cystogenesis$249,000
R00 · FY2018 · DK · contact PI
The involvement of ATP-dependent inhibition of ENaC in ARPKD cystogenesis$88,178
K99 · FY2016 · DK · contact PI
The involvement of ATP-dependent inhibition of ENaC in ARPKD cystogenesis$91,380
K99 · FY2015 · DK · contact PI